HOUSE BILL No. 5137
November 30, 1999, Introduced by Rep. DeWeese and referred to the Committee on Health Policy. A bill to amend 1978 PA 368, entitled "Public health code," by amending sections 7104, 7107, 7109, 7333, 7401, 7403, 7407, 7521, 16204b, 16204c, 16204d, and 16315 (MCL 333.7104, 333.7107, 333.7109, 333.7333, 333.7401, 333.7403, 333.7407, 333.7521, 333.16204b, 333.16204c, 333.16204d, and 333.16315), section 7104 as amended by 1994 PA 38, sections 7107, 7109, and 7407 as amended by 1993 PA 80, section 7333 as amended and section 16315 as added by 1993 PA 138, section 7401 as amended by 1998 PA 319, section 7403 as amended by 1996 PA 249, section 7521 as amended by 1990 PA 30, section 16204b as added by 1998 PA 422, and sec- tions 16204c and 16204d as added by 1998 PA 423; and to repeal acts and parts of acts. THE PEOPLE OF THE STATE OF MICHIGAN ENACT: 00340'99 CPD 2 1 Sec. 7104. (1) "Bureau" means the drug enforcement 2 administration, United States department of justice, or its 3 successor agency. 4 (2) "Controlled substance" means a drug, substance, or imme- 5 diate precursor included in schedules 1 to 5 of part 72. 6 (3) "Controlled substance analogue" means a substance the 7 chemical structure of which is substantially similar to that of a 8 controlled substance in schedule 1 or 2 and OR that has a nar- 9 cotic, stimulant, depressant, or hallucinogenic effect on the 10 central nervous system substantially similar to or greater than 11 the narcotic, stimulant, depressant, or hallucinogenic effect on 12 the central nervous system of a controlled substance included in 13 schedule 1 or 2 or, with respect to a particular individual, that 14 the individual represents or intends to have a narcotic, stimu- 15 lant, depressant, or hallucinogenic effect on the central nervous 16 system substantially similar to or greater than the narcotic, 17 stimulant, depressant, or hallucinogenic effect on the central 18 nervous system of a controlled substance included in schedule 1 19 or 2. Controlled substance analogue does not include any 1 OR 20 MORE of the following: 21 (a) A controlled substance. 22 (b) A substance for which there is an approved new drug 23 application. 24 (c) A substance with respect to which an exemption is in 25 effect for investigational use by a particular person under 26 section 505 of the federal food, drug and cosmetic act, 27 chapter 675, 52 Stat. 1040 1052, 21 U.S.C. 355, to the extent 00340'99 3 1 conduct with respect to the substance is pursuant to the 2 exemption. 3 (d) Any substance to the extent not intended for human con- 4 sumption before an exemption takes effect with respect to the 5 substance. 6 (4) "Counterfeit prescription form" means a printed form 7 that is the same or similar to a prescription form or an offi- 8 cial prescription form, and that was manufactured, printed, 9 duplicated, forged, or altered without the knowledge or permis- 10 sion of a licensed prescribing practitioner. , or, in the case 11 of official prescription forms, the department of commerce. 12 (5) "Counterfeit substance" means a controlled substance 13 which THAT, or the container or labeling of which, without 14 authorization, bears the trademark, trade name or other identify- 15 ing mark, imprint, number, or device, or any likeness thereof, of 16 a manufacturer, distributor, or dispenser other than the person 17 who in fact manufactured, distributed, or dispensed the 18 substance. 19 (6) "Deleterious drug" means a drug, other than a propri- 20 etary medicine, likely to be destructive to adult human life in 21 quantities of 3.88 grams or less. 22 Sec. 7107. (1) "Narcotic drug" means any of the follow- 23 ing, whether produced directly or indirectly by extraction from 24 substances of vegetable origin, or independently by means of 25 chemical synthesis, or by a combination of extraction and chemi- 26 cal synthesis: 00340'99 4 1 (a) Opium and opiate, and any salt, compound, derivative, or 2 preparation of opium or opiate. 3 (b) Any salt, compound, isomer, derivative, or preparation 4 thereof which is chemically equivalent or identical with any of 5 the substances referred to in subdivision (a), but not including 6 the isoquinoline alkaloids of opium. 7 (2) "Official prescription form" means a prescription form 8 that meets the requirements of section 7334 and is issued to 9 practitioners by the department of commerce. 10 Sec. 7109. (1) "Person" means a person as defined in sec- 11 tion 1106 or a governmental entity. 12 (2) "Poppy straw" means all parts, except the seeds, of the 13 opium poppy, after mowing. 14 (3) "Practitioner" means: 15 (a) A prescriber or pharmacist, a scientific investigator as 16 defined by rule of the administrator, or other person licensed, 17 registered, or otherwise permitted to distribute, dispense, con- 18 duct research with respect to, or administer a controlled sub- 19 stance in the course of professional practice or research in this 20 state, including an individual in charge of a dog pound or animal 21 shelter licensed or registered by the department of agriculture 22 pursuant to Act No. 287 of the Public Acts of 1969, being sec- 23 tions 287.331 to 287.340 of the Michigan Compiled Laws 1969 PA 24 287, MCL 287.331 TO 287.340, or a class B dealer licensed by the 25 United States department of agriculture pursuant to the animal 26 welfare act, Public Law 89-544, 7 U.S.C. 2131 to 2147, 2149, and 27 2151 to 2159 and the department of agriculture pursuant to Act 00340'99 5 1 No. 224 of the Public Acts of 1969, being sections 287.381 to 2 287.395 of the Michigan Compiled Laws 1969 PA 224, MCL 287.381 3 TO 287.395, for the limited purpose of buying, possessing, and 4 administering a commercially prepared, premixed solution of 5 sodium pentobarbital to practice euthanasia on animals. 6 (b) A pharmacy, hospital, or other institution or place of 7 professional practice licensed, registered, or otherwise permit- 8 ted to distribute, prescribe, dispense, conduct research with 9 respect to, or administer a controlled substance in the course of 10 professional practice or research in this state. 11 (4) "PRESCRIBER" MEANS THAT TERM AS DEFINED IN SECTION 12 17708. 13 (5) (4) "Prescription form" means a printed form which 14 THAT is authorized and intended for use by a prescribing practi- 15 tioner to prescribe controlled substances or prescription drugs 16 and which THAT meets the requirements of rules promulgated by 17 the administrator. 18 (6) (5) "Production" means the manufacture, planting, cul- 19 tivation, growing, or harvesting of a controlled substance. 20 (7) (6) "Ultimate user" means an individual who lawfully 21 possesses a controlled substance for personal use or for the use 22 of a member of the individual's household, or for administering 23 to an animal owned by the individual or by a member of the 24 individual's household. 25 Sec. 7333. (1) Except as otherwise provided in this 26 section, and section 17766b, a controlled substance included in 27 schedule 2 or an androgenic anabolic steroid as defined in 00340'99 6 1 section 17766a shall not be dispensed without the written 2 prescription of a practitioner licensed under section 7303 on an 3 official A prescription form. A PRACTITIONER SHALL NOT ISSUE 4 MORE THAN 1 PRESCRIPTION FOR A CONTROLLED SUBSTANCE INCLUDED IN 5 SCHEDULE 2 ON A SINGLE PRESCRIPTION FORM. A PRESCRIPTION FOR A 6 CONTROLLED SUBSTANCE INCLUDED IN SCHEDULE 2 SHALL NOT BE 7 REFILLED. 8 (2) In an emergency situation, as defined by rule of the 9 administrator IN R 338.3165 OF THE MICHIGAN ADMINISTRATIVE CODE, 10 a controlled substance included in schedule 2 or an androgenic 11 anabolic steroid may be dispensed upon THE oral prescription of a 12 practitioner. if, except as otherwise provided in this section 13 and section 17766b, the prescribing practitioner promptly fills 14 out an official prescription form and, until January 1, 1995, 15 forwards the first and second copies of the official prescription 16 form or, beginning January 1, 1995, forwards the official pre- 17 scription form to the dispensing pharmacy within 72 hours after 18 the oral prescription is issued, in compliance with 19 section 7334(6). A prescription for an androgenic anabolic ste- 20 roid other than methyltestosterone, testosterone, or fluoxymen- 21 sterone, whether that methyltestosterone, testosterone, or fluo- 22 xymensterone is prescribed alone or in combination with any other 23 drug for which an official prescription form is not required, or 24 for a controlled substance included in schedule 2 shall not be 25 refilled. Except for a terminally ill patient whose terminal 26 illness the pharmacist documents pursuant to rules promulgated by 27 the administrator, a prescription for an androgenic anabolic 00340'99 7 1 steroid other than methyltestosterone, testosterone, or 2 fluoxymensterone, whether that methyltestosterone, testosterone, 3 or fluoxymensterone is prescribed alone or in combination with 4 any other drug for which an official prescription form is not 5 required, or for a controlled substance included in schedule 2 6 shall not be filled more than 5 30 days after the date on which 7 the prescription was issued. A prescription for a controlled 8 substance included in schedule 2 for a terminally ill patient 9 whose terminal illness the pharmacist documents pursuant to rules 10 promulgated by the administrator may be partially filled in 11 increments for not more than 60 days after the date on which the 12 prescription was issued. 13 (3) The following are not required to be on an official 14 prescription form: 15 (a) A controlled substance included in schedule 2 or an 16 androgenic anabolic steroid that is ordered for and administered 17 to a patient in a hospital licensed by the department of public 18 health or the department of mental health. An off-site pharmacy 19 receiving a prescriber's order pursuant to this subdivision shall 20 record the order as required by section 17708(3) and shall retain 21 that record as if it were an official prescription form. 22 (b) A controlled substance included in schedule 2 or an 23 androgenic anabolic steroid that is ordered for and administered 24 to a patient on the premises of a licensed health facility or 25 agency other than a hospital. An off-site pharmacy receiving a 26 prescriber's order pursuant to this subdivision shall record the 00340'99 8 1 order as required by section 17708(3) and shall retain that 2 record as if it were an official prescription form. 3 (c) A controlled substance included in schedule 2 or an 4 androgenic anabolic steroid that is administered to a patient in 5 the private practice office of a licensed physician, dentist, or 6 podiatrist. 7 (d) A controlled substance included in schedule 2 or an 8 androgenic anabolic steroid that is administered to an animal by 9 a licensed veterinarian in a veterinarian's office, animal 10 clinic, animal hospital, zoo, or on the premises of the animal's 11 domicile, and a commercially prepared, premixed solution of 12 sodium pentobarbital administered to an animal for the purpose of 13 euthanasia. 14 (e) A prescription issued by a practitioner residing adja- 15 cent to the land border between this state and an adjoining state 16 who is authorized under the laws of that state to practice a 17 health profession and whose practice may extend into this state, 18 but who does not maintain an office or designate a place to meet 19 patients or receive calls in this state. 20 (f) A prescription for methyltestosterone, testosterone, or 21 fluoxymensterone, alone or in combination with any other drug for 22 which an official prescription form is not required. 23 (g) A controlled substance described in section 24 7214(c)(iv). 25 (3) (4) Unless dispensed directly by a practitioner, other 26 than a pharmacist, to an ultimate user, a controlled substance 27 included in schedule 3 or 4 that is a prescription drug as 00340'99 9 1 determined under section 503(b) of the federal food, drug, and 2 cosmetic act, chapter 675, 52 Stat. 1040 1051, 21 U.S.C. 353 or 3 section 17708, shall not be dispensed without a written 4 PRESCRIPTION ON A PRESCRIPTION FORM or AN oral prescription of a 5 practitioner. The A prescription FOR A CONTROLLED SUBSTANCE 6 INCLUDED IN SCHEDULE 3 OR 4 shall not be filled or refilled with- 7 out specific refill instructions noted by the prescriber 8 PRACTITIONER. The A prescription FOR A CONTROLLED SUBSTANCE 9 INCLUDED IN SCHEDULE 3 OR 4 shall not be filled or refilled later 10 than 6 months after the date of the prescription or be refilled 11 more than 5 times, unless renewed by the practitioner in accord- 12 ance with rules promulgated by the administrator. 13 (4) (5) A controlled substance included in schedule 5 14 shall not be distributed or dispensed other than for a medical 15 purpose, or in any manner except in accordance with rules promul- 16 gated by the administrator. 17 (5) (6) If a written prescription is required under this 18 section, the written prescription shall contain the quantity of 19 the controlled substance or androgenic anabolic steroid pre- 20 scribed in both written and numerical terms. A written prescrip- 21 tion is in compliance with this subsection if, in addition to 22 containing the quantity of the controlled substance or androge- 23 nic anabolic steroid prescribed in written terms, it contains 24 preprinted numbers representative of the quantity of the con- 25 trolled substance or an androgenic anabolic steroid prescribed 26 next to which is a box or line the prescriber may check. A 27 PRACTITIONER WHO PRESCRIBES A CONTROLLED SUBSTANCE SHALL ENTER 00340'99 10 1 THE NAME OF THE CONTROLLED SUBSTANCE, THE DOSAGE, THE QUANTITY 2 PRESCRIBED, AND THE INSTRUCTIONS FOR USE IN THE PATIENT'S PER- 3 MANENT MEDICAL RECORD. 4 (6) (7) A prescribing practitioner shall not use a pre- 5 scription form for a purpose other than prescribing. A pre- 6 scribing practitioner shall not postdate an official prescription 7 form. A prescribing practitioner shall not sign an official pre- 8 scription form on a day other than the day the prescription is 9 issued. A PRESCRIBING PRACTITIONER SHALL NOT POSTDATE A PRE- 10 SCRIPTION FORM FOR A CONTROLLED SUBSTANCE. 11 (7) (8) Notwithstanding subsections (1) to (7) (4), a 12 dog pound or animal shelter licensed or registered by the depart- 13 ment of agriculture pursuant to Act No. 287 of the Public Acts 14 of 1969, being sections 287.331 to 287.340 of the Michigan 15 Compiled Laws 1969 PA 287, MCL 287.331 TO 287.340, or a class B 16 dealer may acquire a limited permit only for the purpose of 17 buying, possessing, and administering a commercially prepared, 18 premixed solution of sodium pentobarbital to practice euthanasia 19 on injured, sick, homeless, or unwanted domestic pets and other 20 animals, if the dog pound or animal shelter or class B dealer 21 does all of the following: 22 (a) Applies to the administrator for a permit in accordance 23 with rules promulgated under this part. The application shall 24 contain the name of the individual in charge of the day to day 25 operations of the dog pound or animal shelter or class B dealer's 26 facilities and the name of the individual responsible for 00340'99 11 1 designating employees who will be practicing euthanasia on 2 animals pursuant to this act. 3 (b) Complies with the rules promulgated by the administrator 4 for the storage, handling, and use of commercially prepared, pre- 5 mixed solution of sodium pentobarbital to practice euthanasia on 6 animals. A record of use shall be maintained and shall be avail- 7 able for inspection. 8 (c) Certifies that an employee of the dog pound or animal 9 shelter or class B dealer has received, and can document comple- 10 tion of, a minimum of 8 hours of training given by a licensed 11 veterinarian in the use of sodium pentobarbital to practice 12 euthanasia on animals pursuant to rules promulgated by the admin- 13 istrator, in consultation with the Michigan board of veterinary 14 medicine as these rules relate to this training, and that only an 15 individual described in this subdivision or an individual other- 16 wise permitted to use a controlled substance pursuant to this 17 article will administer the commercially prepared, premixed solu- 18 tion of sodium pentobarbital according to written procedures 19 established by the dog pound or animal shelter or class B 20 dealer. 21 (8) (9) The application described in subsection (8) (7) 22 shall include the names and addresses of all individuals employed 23 by the dog pound or animal shelter or class B dealer who have 24 been trained as described in subsection (8)(c) (7)(C) and the 25 name of the veterinarian who trained them. The list of names and 26 addresses shall be updated every 6 months. 00340'99 12 1 (9) (10) If a dog pound or animal shelter or class B 2 dealer issued a permit pursuant to subsection (8) (7) does not 3 have in its employ an individual trained as described in subsec- 4 tion (8)(c) (7)(C), the dog pound or animal shelter or class B 5 dealer shall immediately notify the administrator and shall cease 6 to administer any commercially prepared, premixed solution of 7 sodium pentobarbital until the administrator is notified that 1 8 of the following has occurred: 9 (a) An individual trained as described in subsection 10 (8)(c) (7)(C) has been hired by the dog pound or animal shelter 11 or class B dealer. 12 (b) An employee of the dog pound or animal shelter or class 13 B dealer has been trained as described in subsection (8)(c) 14 (7)(C). 15 (10) (11) A veterinarian, including a veterinarian who 16 trains individuals as described in subsection (8)(c) (7)(C), is 17 not civilly or criminally liable for the use of a commercially 18 prepared, premixed solution of sodium pentobarbital by a dog 19 pound or animal shelter or class B dealer unless the veterinarian 20 is employed by or under contract with the dog pound or animal 21 shelter or class B dealer and the terms of the veterinarian's 22 employment or the contract require the veterinarian to be respon- 23 sible for the use or administration of the commercially prepared, 24 premixed solution of sodium pentobarbital. 25 (11) (12) A person shall not knowingly use or permit the 26 use of a commercially prepared, premixed solution of sodium 27 pentobarbital in violation of this section. 00340'99 13 1 (12) (13) This section does not require that a 2 veterinarian be employed by or under contract with a dog pound or 3 animal shelter or class B dealer to obtain, possess, or adminis- 4 ter a commercially prepared, premixed solution of sodium pento- 5 barbital pursuant to this section. 6 (13) (14) As used in this section, "class B dealer" means 7 a class B dealer licensed by the United States department of 8 agriculture pursuant to the animal welfare act, Public Law 9 89-544, 7 U.S.C. 2131 to 2147, 2149, and 2151 to 2159 and the 10 department of agriculture pursuant to Act No. 224 of the Public 11 Acts of 1969, being sections 287.381 to 287.395 of the Michigan 12 Compiled Laws 1969 PA 224, MCL 287.381 TO 287.395. 13 Sec. 7401. (1) Except as authorized by this article, a 14 person shall not manufacture, create, deliver, or possess with 15 intent to manufacture, create, or deliver a controlled substance, 16 a prescription form, an official prescription form, or a coun- 17 terfeit prescription form. A practitioner licensed by the admin- 18 istrator under this article shall not dispense, prescribe, or 19 administer a controlled substance for other than legitimate and 20 professionally recognized therapeutic or scientific purposes or 21 outside the scope of practice of the practitioner, licensee, or 22 applicant. 23 (2) A person who violates this section as to: 24 (a) A controlled substance classified in schedule 1 or 2 25 that is a narcotic drug or a drug described in section 26 7214(a)(iv) and: 00340'99 14 1 (i) Which is in an amount of 650 grams or more of any 2 mixture containing that substance is guilty of a felony 3 punishable by imprisonment for life or any term of years but not 4 less than 20 years. 5 (ii) Which is in an amount of 225 grams or more, but less 6 than 650 grams, of any mixture containing that substance is 7 guilty of a felony and shall be imprisoned for not less than 20 8 years nor more than 30 years. 9 (iii) Which is in an amount of 50 grams or more, but less 10 than 225 grams, of any mixture containing that substance is 11 guilty of a felony and shall be imprisoned for not less than 10 12 years nor more than 20 years. 13 (iv) Which is in an amount less than 50 grams, of any mix- 14 ture containing that substance is guilty of a felony and shall be 15 imprisoned for not less than 1 year nor more than 20 years, and 16 may be fined not more than $25,000.00, or placed on probation for 17 life. 18 (b) Any other controlled substance classified in schedule 1, 19 2, or 3, except marihuana is guilty of a felony punishable by 20 imprisonment for not more than 7 years or a fine of not more than 21 $10,000.00, or both. 22 (c) A substance classified in schedule 4 is guilty of a 23 felony punishable by imprisonment for not more than 4 years or a 24 fine of not more than $2,000.00, or both. 25 (d) Marihuana or a mixture containing marihuana is guilty of 26 a felony punishable as follows: 00340'99 15 1 (i) If the amount is 45 kilograms or more, or 200 plants or 2 more, by imprisonment for not more than 15 years or a fine of not 3 more than $10,000,000.00, or both. 4 (ii) If the amount is 5 kilograms or more but less than 45 5 kilograms, or 20 plants or more but fewer than 200 plants, by 6 imprisonment for not more than 7 years or a fine of not more than 7 $500,000.00, or both. 8 (iii) If the amount is less than 5 kilograms or fewer than 9 20 plants, by imprisonment for not more than 4 years or a fine of 10 not more than $20,000.00, or both. 11 (e) A substance classified in schedule 5 is guilty of a 12 felony punishable by imprisonment for not more than 2 years or a 13 fine of not more than $2,000.00, or both. 14 (f) An official prescription form or a counterfeit official 15 prescription form is guilty of a felony punishable by imprison- 16 ment for not more than 20 years or a fine of not more than 17 $25,000.00, or both. 18 (F) (g) A prescription form or a counterfeit prescription 19 form other than an official prescription form or a counterfeit 20 official prescription form is guilty of a felony punishable by 21 imprisonment for not more than 7 years or a fine of not more than 22 $5,000.00, or both. 23 (3) A term of imprisonment imposed pursuant to subsection 24 (2)(a) or section 7403(2)(a)(i), (ii), (iii), or (iv) shall be 25 imposed to run consecutively with any term of imprisonment 26 imposed for the commission of another felony. An individual 27 subject to a mandatory term of imprisonment under subsection 00340'99 16 1 (2)(a) or section 7403(2)(a)(i), (ii), (iii), or (iv) shall not 2 be eligible for probation, suspension of that sentence, or parole 3 during that mandatory term, except and only to the extent that 4 those provisions permit probation for life, and shall not receive 5 a reduction in that mandatory term of imprisonment by disci- 6 plinary credits or any other type of sentence credit reduction. 7 (4) The court may depart from the minimum term of imprison- 8 ment authorized under subsection (2)(a)(ii), (iii), or (iv) if 9 the court finds on the record that there are substantial and com- 10 pelling reasons to do so. In addition, if any of the following 11 apply, the court may depart from the minimum term of imprisonment 12 authorized under subsection (2)(a)(ii), (iii), or (iv) if the 13 individual has not previously been convicted of a felony or an 14 assaultive crime and has not been convicted of another felony or 15 assaultive crime arising from the same transaction as the viola- 16 tion of this section: 17 (a) The person is within the jurisdiction of the circuit 18 court under section 606 of the revised judicature act of 1961, 19 1961 PA 236, MCL 600.606, or section 4 of chapter XIIA of 1939 20 PA 288, MCL 712A.4. 21 (b) The person is being sentenced under section 18(1)(n) of 22 chapter XIIA of 1939 PA 288, MCL 712A.18. 23 (5) As used in this section: 24 (a) "Assaultive crime" means a violation of chapter XI of 25 the Michigan penal code, 1931 PA 328, MCL 750.81 to 750.90. 00340'99 17 1 (b) "Plant" means a marihuana plant that has produced 2 cotyledons or a cutting of a marihuana plant that has produced 3 cotyledons. 4 Sec. 7403. (1) A person shall not knowingly or intention- 5 ally possess a controlled substance, a controlled substance anal- 6 ogue, or an official prescription form or a prescription form 7 unless the controlled substance, controlled substance analogue, 8 official prescription form, or prescription form was obtained 9 directly from, or pursuant to, a valid prescription or order of a 10 practitioner while acting in the course of the practitioner's 11 professional practice, or except as otherwise authorized by this 12 article. 13 (2) A person who violates this section as to: 14 (a) A controlled substance classified in schedule 1 or 2 15 that is a narcotic drug or a drug described in section 16 7214(a)(iv), and: 17 (i) Which is in an amount of 650 grams or more of any mix- 18 ture containing that substance is guilty of a felony and shall be 19 imprisoned for life except as otherwise provided in this 20 subparagraph. A person convicted of violating this subparagraph 21 may be punished as provided by law by imposing a sentence of 22 imprisonment for any term of years but not less than 25 years if 23 any of the following apply: 24 (A) The person is within the jurisdiction of the circuit 25 court or recorder's court of the city of Detroit under 26 section 606 of the revised judicature act of 1961, Act No. 236 27 of the Public Acts of 1961, being section 600.606 of the Michigan 00340'99 18 1 Compiled Laws 1961 PA 236, MCL 600.606, OR section 4 of chapter 2 XIIA of Act No. 288 of the Public Acts of 1939, being 3 section 712A.4 of the Michigan Compiled Laws, or 4 section 10a(1)(c) of Act No. 369 of the Public Acts of 1919, 5 being section 725.10a of the Michigan Compiled Laws THE PROBATE 6 CODE OF 1939, 1939 PA 288, MCL 712A.4. 7 (B) The person is being sentenced under section 18(1)(n) of 8 chapter XIIA of Act No. 288 of the Public Acts of 1939, being 9 section 712A.18 of the Michigan Compiled Laws THE PROBATE CODE 10 OF 1939, 1939 PA 288, MCL 712A.18. 11 (ii) Which is in an amount of 225 grams or more, but less 12 than 650 grams, of any mixture containing that substance is 13 guilty of a felony and shall be imprisoned for not less than 20 14 years nor more than 30 years. 15 (iii) Which is in an amount of 50 grams or more, but less 16 than 225 grams, of any mixture containing that substance is 17 guilty of a felony and shall be imprisoned for not less than 10 18 years nor more than 20 years. 19 (iv) Which is in an amount of 25 grams or more, but less 20 than 50 grams of any mixture containing that substance is guilty 21 of a felony and shall be imprisoned for not less than 1 year and 22 not more than 4 years, and may be fined not more than $25,000.00 23 or placed on probation for life. 24 (v) Which is in an amount less than 25 grams of any mixture 25 containing that substance is guilty of a felony punishable by 26 imprisonment for not more than 4 years or a fine of not more than 27 $25,000.00, or both. 00340'99 19 1 (b) A controlled substance classified in schedule 1, 2, 3, 2 or 4, except a controlled substance for which a penalty is pre- 3 scribed in subdivision (a), (c), or (d), or a controlled sub- 4 stance analogue is guilty of a felony punishable by imprisonment 5 for not more than 2 years or a fine of not more than $2,000.00, 6 or both. 7 (c) Lysergic acid diethylamide, peyote, mescaline, dimethyl- 8 tryptamine, psilocyn, psilocybin, or a controlled substance clas- 9 sified in schedule 5, is guilty of a misdemeanor punishable by 10 imprisonment for not more than 1 year or a fine of not more than 11 $2,000.00, or both. 12 (d) Marihuana, is guilty of a misdemeanor punishable by 13 imprisonment for not more than 1 year or a fine of not more than 14 $2,000.00, or both. 15 (e) An official prescription form, is guilty of a felony 16 punishable by imprisonment for not more than 1 year or a fine of 17 not more than $2,000.00, or both. 18 (E) (f) A prescription form, other than an official pre- 19 scription form, is guilty of a misdemeanor punishable by impris- 20 onment for not more than 1 year or a fine of not more than 21 $1,000.00, or both. 22 (3) The court may depart from the minimum term of imprison- 23 ment authorized under subsection (2)(a)(ii), (iii), or (iv) if 24 the court finds on the record that there are substantial and com- 25 pelling reasons to do so. In addition, if any of the following 26 apply, the court may depart from the minimum term of imprisonment 27 authorized under subsection (2)(a)(ii), (iii), or (iv) if the 00340'99 20 1 individual has not previously been convicted of a felony or an 2 assaultive crime and has not been convicted of another felony or 3 assaultive crime arising from the same transaction as the viola- 4 tion of this section: 5 (a) The person is within the jurisdiction of the circuit 6 court or recorder's court of the city of Detroit under 7 section 606 of the revised judicature act of 1961, Act No. 236 8 of the Public Acts of 1961, being section 600.606 of the Michigan 9 Compiled Laws 1961 PA 236, MCL 600.606, OR section 4 of chapter 10 XIIA of Act No. 288 of the Public Acts of 1939, being 11 section 712A.4 of the Michigan Compiled Laws, or 12 section 10a(1)(c) of Act No. 369 of the Public Acts of 1919, 13 being section 725.10a of the Michigan Compiled Laws THE PROBATE 14 CODE OF 1939, 1939 PA 288, MCL 712A.4. 15 (b) The person is being sentenced under section 18(1)(n) of 16 chapter XIIA of Act No. 288 of the Public Acts of 1939, being 17 section 712A.18 of the Michigan Compiled Laws THE PROBATE CODE 18 OF 1939, 1939 PA 288, MCL 712A.18. 19 (4) As used in subsection (3), "assaultive crime" means a 20 violation of chapter XI of the Michigan penal code, Act No. 328 21 of the Public Acts of 1931, being sections 750.81 to 750.90 of 22 the Michigan Compiled Laws 1931 PA 328, MCL 750.81 TO 750.90. 23 Sec. 7407. (1) A person shall not knowingly or 24 intentionally: 25 (a) Distribute as a licensee a controlled substance classi- 26 fied in schedule 1 or 2, except pursuant to an order form as 27 required by section 7331. 00340'99 21 1 (b) Use in the course of the manufacture or distribution of 2 a controlled substance a license number which THAT is ficti- 3 tious, revoked, suspended, or issued to another person. 4 (c) Acquire or obtain possession of a controlled substance 5 by misrepresentation, fraud, forgery, deception, or subterfuge. 6 (d) Furnish false or fraudulent material information in, or 7 omit any material information from, an application, report, 8 official prescription form, or other document required to be 9 kept or filed under this article, or any record required to be 10 kept by this article. 11 (e) Make, distribute, or possess a punch, die, plate, stone, 12 or other thing designed to print, imprint, or reproduce the 13 trademark, trade name, or other identifying mark, imprint, or 14 device of another or any likeness of any of the foregoing upon a 15 drug or container or labeling thereof so as to render the drug a 16 counterfeit substance. 17 (f) Knowingly and intentionally give, permit, or obtain 18 access to information submitted to the department of commerce 19 under section 7334, except as otherwise authorized by this 20 article. 21 (F) (g) Possess counterfeit prescription forms, except as 22 an agent of government while engaged in the enforcement of this 23 part. 24 (2) A person shall not refuse or knowingly fail to make, 25 keep, or furnish any record, notification, order form, statement, 26 invoice, or other information required under this article. 00340'99 22 1 (3) A person who violates this section is guilty of a 2 felony, punishable by imprisonment for not more than 4 years, or 3 a fine of not more than $30,000.00, or both. 4 Sec. 7521. (1) The following property is subject to 5 forfeiture: 6 (a) A prescription form, official prescription form, con- 7 trolled substance, an imitation controlled substance, a con- 8 trolled substance analogue, an androgenic anabolic steroid, or a 9 counterfeit androgenic anabolic steroid which THAT has been 10 manufactured, distributed, dispensed, used, possessed, or 11 acquired in violation of this article or section 17766a. 12 (b) A raw material, product, or equipment of any kind which 13 is used, or intended for use, in manufacturing, compounding, pro- 14 cessing, delivering, importing, or exporting a controlled sub- 15 stance, a controlled substance analogue, an androgenic anabolic 16 steroid, or a counterfeit androgenic anabolic steroid in viola- 17 tion of this article or section 17766a; or a raw material, pro- 18 duct, or equipment of any kind which is intended for use in manu- 19 facturing, compounding, processing, delivering, importing, or 20 exporting an imitation controlled substance in violation of 21 section 7341. 22 (c) Property which is used, or intended for use, as a con- 23 tainer for property described in subdivision (a) or (b). 24 (d) Except as provided in subparagraphs (i) to (iv), a con- 25 veyance, including an aircraft, vehicle, or vessel used or 26 intended for use, to transport, or in any manner to facilitate 00340'99 23 1 the transportation, for the purpose of sale or receipt of 2 property described in subdivision (a) or (b): 3 (i) A conveyance used by a person as a common carrier in the 4 transaction of business as a common carrier is not subject to 5 forfeiture unless it appears that the owner or other person in 6 charge of the conveyance is a consenting party or privy to a vio- 7 lation of this article. 8 (ii) A conveyance is not subject to forfeiture by reason of 9 any act or omission established by the owner of that conveyance 10 to have been committed or omitted without the owner's knowledge 11 or consent. 12 (iii) A conveyance is not subject to forfeiture for a viola- 13 tion of section 7403(2)(c) or (d), section 7404, or 14 section 7341(4). 15 (iv) A forfeiture of a conveyance encumbered by a bona fide 16 security interest is subject to the interest of the secured party 17 who neither had knowledge of nor consented to the act or 18 omission. 19 (e) Books, records, and research products and materials, 20 including formulas, microfilm, tapes, and data used, or intended 21 for use, in violation of this article or section 17766a. 22 (f) Any thing of value that is furnished or intended to be 23 furnished in exchange for a controlled substance, an imitation 24 controlled substance, an androgenic anabolic steroid, or a coun- 25 terfeit androgenic anabolic steroid in violation of this article 26 or section 17766a that is traceable to an exchange for a 27 controlled substance, an imitation controlled substance, an 00340'99 24 1 androgenic anabolic steroid, or a counterfeit androgenic anabolic 2 steroid in violation of this article or section 17766a, or that 3 is used or intended to be used to facilitate any violation of 4 this article or section 17766a including, but not limited to, 5 money, negotiable instruments, or securities. To the extent of 6 the interest of an owner, a thing of value is not subject to for- 7 feiture under this subdivision by reason of any act or omission 8 that is established by the owner of the item to have been commit- 9 ted or omitted without the owner's knowledge or consent. Any 10 money that is found in close proximity to any property that is 11 subject to forfeiture under subdivision (a), (b), (c), (d), or 12 (e) shall be IS presumed to be subject to forfeiture under this 13 subdivision. This presumption may be rebutted by clear and con- 14 vincing evidence. 15 (g) Any other drug paraphernalia not described in subdivi- 16 sion (b) or (c). 17 (2) As used in this section: 18 (a) "Androgenic anabolic steroid" means that term as defined 19 in section 17766a. 20 (b) "Counterfeit androgenic anabolic steroid" means that 21 term as defined in section 17766a. 22 (c) "Imitation controlled substance" means that term as 23 defined in section 7341. 24 Sec. 16204b. (1) The legislature finds that the treatment 25 of intractable pain is an appropriate issue for the legislature 26 to consider, and that the citizens of this state would be well 00340'99 25 1 served by the enactment of legislation that accomplishes all of 2 the following: 3 (a) Provides more and better information to health care con- 4 sumers regarding the medical treatment of intractable pain, 5 health care coverage and benefits for the treatment of intracta- 6 ble pain, and the education of health professionals in pain and 7 symptom management. 8 (b) Provides for the appointment of an advisory body to 9 study and make recommendations on model core curricula on pain 10 and symptom management for the institutions in this state provid- 11 ing health care education, continuing education for health pro- 12 fessionals on pain and symptom management, and the integration of 13 pain and symptom management into the customary practice of health 14 care. 15 (c) Educates health professionals about the official pre- 16 scription form program and the disciplinary process for state 17 licensees and registrants, including, but not limited to, how the 18 department of consumer and industry services processes allega- 19 tions of wrongdoing against licensees and registrants. 20 (2) As used in this section, : (a) "Intractable 21 "INTRACTABLE pain" means that term as defined in section 16204a. 22 (b) "Official prescription form" means that term as defined 23 in section 7107. 24 Sec. 16204c. (1) The legislature finds that the use of con- 25 trolled substances is appropriate in the medical treatment of 26 certain forms of intractable pain, and that efforts to control 27 diversion or improper administration of controlled substances 00340'99 26 1 should not interfere with the legitimate, medically recognized 2 use of those controlled substances to relieve pain and 3 suffering. 4 (2) The legislature finds all of the following: (a) That 5 THAT some patients in this state with intractable pain are unable 6 to obtain from their health care providers sufficient pain relief 7 through the prescription of controlled substances, especially 8 controlled substances included in schedule 2 under section 7214. 9 , due to the circumstances described in subdivision (b). 10 (b) The regulatory scheme of official prescription forms 11 created in sections 7333 and 7334 is perceived in some cases to 12 discourage the appropriate use of opioids in the treatment of 13 patients described in subdivision (a). 14 (3) Based on the findings described in subsections (1) and 15 (2), the legislature states that the official prescription form 16 program enacted in sections 7333 and 7334 was created to prevent 17 the abuse and diversion of controlled substances included in 18 schedule 2 under section 7214 and not to prevent or inhibit the 19 legitimate, medically recognized use of those controlled sub- 20 stances to treat patients with cases of intractable pain, espe- 21 cially long-term treatment. It is the intent of the legislature 22 to permit and facilitate adequate treatment for intractable pain 23 by licensed health professionals, including, but not limited to, 24 the prescription or dispensing of controlled substances included 25 in schedule 2 under section 7214, when medically appropriate. 26 (4) As used in this section: 00340'99 27 1 (a) "Controlled substance" means that term as defined in 2 section 7104. 3 (b) "Intractable pain" means that term as defined in section 4 16204a. 5 (c) "Official prescription form" means that term as defined 6 in section 7107. 7 Sec. 16204d. (1) The department of consumer and industry 8 services, in consultation with the department of community 9 health, shall develop, publish, and distribute an informational 10 booklet on intractable pain. The department of consumer and 11 industry services shall include at least all of the following in 12 the informational booklet: 13 (a) The definition of intractable pain contained in section 14 16204a. 15 (b) Pain management educational curricula and continuing 16 educational requirements of institutions providing health care 17 education recommended by the advisory committee on pain and symp- 18 tom management under section 16204a. 19 (c) Other information considered relevant or useful by the 20 department of consumer and industry services. 21 (2) The department of consumer and industry services , in 22 conjunction with the controlled substances advisory commission 23 created in article 7, shall develop and conduct an educational 24 program for health professionals who are licensed under part 73 25 to prescribe or dispense, or both, controlled substances. The 26 department of consumer and industry services shall include, at a 27 minimum, all of the following in the educational program: 00340'99 28 1 (a) Information on the history and purpose of the official 2 prescription form program created in sections 7333 and 7334. 3 (b) Information on how the department of consumer and indus- 4 try services collects, processes, and compiles official prescrip- 5 tion form information. 6 (A) (c) Information on how the department of consumer and 7 industry services processes allegations of wrongdoing against 8 licensees under this article and article 17, including, but not 9 limited to, how the permanent historical record is maintained for 10 each licensee, how and why a review of the permanent historical 11 record is done, and how the decision is made to issue a formal 12 complaint against a licensee. 13 (B) (d) Information on the disciplinary process, including 14 a licensee's rights and duties if an allegation of wrongdoing is 15 filed against the licensee or if some other circumstance occurs 16 that causes or requires the department of consumer and industry 17 services to review a licensee's individual historical record. 18 (C) (e) Other information considered relevant or useful by 19 the department of consumer and industry services, or the con- 20 trolled substances advisory commission, especially information 21 that would address the findings and statements of intent con- 22 tained in section 16204c. 23 Sec. 16315. (1) The health professions regulatory fund is 24 established in the state treasury. Except as otherwise provided 25 in this section, the state treasurer shall credit the fees col- 26 lected under sections 16319 to 16349 to the health professions 00340'99 29 1 regulatory fund. The money in the health professions regulatory 2 fund shall be expended only as provided in subsection (5). 3 (2) The state treasurer shall direct the investment of the 4 health professions regulatory fund. Interest and earnings from 5 health professions regulatory fund investment shall be credited 6 to the health professions regulatory fund. 7 (3) The unencumbered balance in the health professions regu- 8 latory fund at the close of the fiscal year shall remain in the 9 health professions regulatory fund and shall not revert to the 10 general fund. 11 (4) The health professions regulatory fund may receive gifts 12 and devises and other money as provided by law. 13 (5) The department OF CONSUMER AND INDUSTRY SERVICES shall 14 use the health professions regulatory fund only to carry out its 15 powers and duties under this article and article 7 including, but 16 not limited to, reimbursing the department of attorney general 17 for the reasonable cost of services provided to the department of 18 commerce CONSUMER AND INDUSTRY SERVICES under this article and 19 article 7. 20 (6) The nurse professional fund is established in the state 21 treasury. Of the money that is attributable to per-year license 22 fees collected under section 16327, the state treasurer shall 23 credit $2.00 of each individual annual license fee collected to 24 the nurse professional fund. The money in the nurse professional 25 fund shall be expended only as provided in subsection (9). 26 (7) The state treasurer shall direct the investment of the 27 nurse professional fund, and shall credit interest and earnings 00340'99 30 1 from the investment to the nurse professional fund. The nurse 2 professional fund may receive gifts and devises and other money 3 as provided by law. 4 (8) The unencumbered balance in the nurse professional fund 5 at the close of the fiscal year shall remain in the nurse profes- 6 sional fund and shall not revert to the general fund. 7 (9) The department OF CONSUMER AND INDUSTRY SERVICES shall 8 use the nurse professional fund each fiscal year only as 9 follows: 10 (a) The department may use not more than 1/3 of the nurse 11 professional fund for the establishment and operation of a nurse 12 continuing education program. 13 (b) The department may use not more than 1/3 of the nurse 14 professional fund to perform research and development studies to 15 promote and advance the nursing profession. 16 (c) The department shall use not less than 1/3 of the nurse 17 professional fund to establish and operate a nursing scholarship 18 program. 19 (10) Within 2 years after the effective date of this 20 section BY APRIL 1, 1996, the department OF CONSUMER AND INDUS- 21 TRY SERVICES shall promulgate rules to implement subsection (9) 22 including, but not limited to, rules governing the continuing 23 education program and rules to establish eligibility criteria for 24 participation in the nursing scholarship program, application 25 procedures, and maximum amounts for individual scholarships. 26 (11) The official prescription form program fund is 27 established in the state treasury and shall be administered by 00340'99 31 1 the department BY THE AMENDATORY ACT THAT ADDED THIS SECTION IS 2 ABOLISHED. THE MONEY REMAINING IN THE OFFICIAL PRESCRIPTION FORM 3 PROGRAM FUND ON THE EFFECTIVE DATE OF THE AMENDATORY ACT THAT 4 ADDED SUBSECTION (12) SHALL BE TRANSFERRED BY THE STATE TREASURER 5 TO THE HEALTH PROFESSIONS REGULATORY FUND CREATED IN SUBSECTION 6 (1). 7 (12) THE PAIN MANAGEMENT EDUCATION AND CONTROLLED SUBSTANCES 8 ANTI-DIVERSION FUND IS ESTABLISHED IN THE STATE TREASURY. 9 (13) THE STATE TREASURER SHALL DIRECT THE INVESTMENT OF THE 10 FUND. INTEREST AND EARNINGS FROM INVESTMENT OF THE FUND SHALL BE 11 CREATED TO THE FUND. 12 (14) THE UNENCUMBERED BALANCE IN THE FUND AT THE CLOSE OF 13 THE FISCAL YEAR SHALL REMAIN IN THE FUND AND SHALL NOT REVERT TO 14 THE GENERAL FUND. THE FUND MAY RECEIVE GIFTS AND DEVISES AND 15 OTHER MONEY AS PROVIDED BY LAW. Twenty dollars of the license fee 16 received by the department OF CONSUMER AND INDUSTRY SERVICES 17 under section 16319 shall be deposited with the state treasurer 18 to the credit of the official prescription form program fund. 19 The department shall use the fund only in connection with pro- 20 grams relating to the official prescription forms required under 21 article 7. Any unexpended balance in the fund at the end of a 22 fiscal year shall carry forward to the next fiscal year. PAIN 23 MANAGEMENT EDUCATION FOR HEALTH PROFESSIONALS AND PREVENTING THE 24 DIVERSION OF CONTROLLED SUBSTANCES. AS USED IN THIS SUBSECTION 25 AND IN SUBSECTIONS (12) AND (13), "FUND" MEANS THE PAIN MANAGE- 26 MENT EDUCATION AND CONTROLLED SUBSTANCES ANTI-DIVERSION FUND. 00340'99 32 1 Enacting section 1. Sections 7111, 7112, 7113, 7334, and 2 17766b of the public health code, 1978 PA 368, MCL 333.7111, 3 333.7112, 333.7113, 333.7334, and 333.17766b, are repealed. 00340'99 Final page. CPD